Dysport® Cosmetic Injection was approved on May 1, 2009 in the United States as a new regimen for wrinkles located on the forehead and facial frown lines. Made by Ipsen Diopharm Ltd, Dysport is now the second drug in the US that has been approved for wrinkles. Dysport has been used in many other countries for nearly 20 years. Dysport was previously known as Reloxin and contains the same active ingredient as Botox, Clostridium Botulinim toxin. This works to reduce the look of wrinkles by limiting the muscle actions that are causing the creased lines. Similar to Botox, Dysport is injected into the site where the wrinkle or line is located.The approval of Dysport was based on clinical trials of 2,900 people in 80 study sites. One trial shows that between 93% and 95% of those studied saw improvement in the look of their forehead wrinkles in just seven days and with additional treatment they saw a difference that lasted for over 13 months. Ipsen has also given distribution rights to Medicis for the drug’s use in cosmetics. Medicis believes this regimen for wrinkles will be on the market within 30 to 60 days in the United States.
Tags: botox, cosmetic dermatology, dysport, frown lines, reloxin, wrinkle injection, wrinkles
Leave a Reply